Clinical Trials Directory

Trials / Unknown

UnknownNCT05482815

Evaluation of the Safety and Efficacy of Voice Prosthesis in Voice Reconstruction After Total Laryngectomy

Evaluation of the Safety and Efficacy of Voice Prosthesis in Voice Reconstruction After Total Laryngectomy: a Prospective, Multicenter, Self-controlled Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Atos Medical AB · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to evaluate the clinical safety and efficacy of voice prosthesis for voice reconstruction after total laryngectomy in China. Main outcome will be the assessment of pronunciation effect (subjective auditory assessment).

Conditions

Interventions

TypeNameDescription
DEVICEProvox Vega Voice prosthesisVoice prosthesis for speech rehabilitation, Provox Vega Voice prosthesis

Timeline

Start date
2021-05-05
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2022-08-01
Last updated
2023-09-13

Locations

3 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05482815. Inclusion in this directory is not an endorsement.